Company Data
RenovoRx Inc.
Ticker
RNXT
Current Price
$1.08 -2.7%
Market Cap
$39.6M
Price Target
Refer to Report
Volume
489.7K
52wk Range
$0.75 - $1.6899
Overview
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.